224 related articles for article (PubMed ID: 20515403)
21. [Investigations on preparation and release behavior in vitro of 9-nitro camptothecin encapsulated micelles].
Gao J; Ming J; Gu Z; Zhang X
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Dec; 25(6):1338-43. PubMed ID: 19166205
[TBL] [Abstract][Full Text] [Related]
22. A stabilizer-free and organic solvent-free method to prepare 10-hydroxycamptothecin nanocrystals: in vitro and in vivo evaluation.
Yang X; Liu Y; Zhao Y; Han M; Guo Y; Kuang H; Wang X
Int J Nanomedicine; 2016; 11():2979-94. PubMed ID: 27382284
[TBL] [Abstract][Full Text] [Related]
23. Effect of a controlled-release drug delivery system made of oleanolic acid formulated into multivesicular liposomes on hepatocellular carcinoma in vitro and in vivo.
Luo Y; Liu Z; Zhang X; Huang J; Yu X; Li J; Xiong D; Sun X; Zhong Z
Int J Nanomedicine; 2016; 11():3111-29. PubMed ID: 27471381
[TBL] [Abstract][Full Text] [Related]
24. [Preparation of PEG-modified nanostructured lipid carriers loaded with hydroxycamptothecin and tissue distribution in mice].
Zhang XX; Gan Y; Yang XG; Zhu CL; Gan L; Nie SF; Pan WS
Yao Xue Xue Bao; 2008 Jan; 43(1):91-6. PubMed ID: 18357740
[TBL] [Abstract][Full Text] [Related]
25. Preparation, characterization, and in vivo evaluation of insulin-loaded PLA-PEG microspheres for controlled parenteral drug delivery.
Sheshala R; Peh KK; Darwis Y
Drug Dev Ind Pharm; 2009 Nov; 35(11):1364-74. PubMed ID: 19832637
[TBL] [Abstract][Full Text] [Related]
26. Sustained delivery of human growth hormone using a polyelectrolyte complex-loaded thermosensitive polyphosphazene hydrogel.
Park MR; Chun C; Ahn SW; Ki MH; Cho CS; Song SC
J Control Release; 2010 Nov; 147(3):359-67. PubMed ID: 20713099
[TBL] [Abstract][Full Text] [Related]
27. Preparation, characterization, biodistribution and antitumor efficacy of hydroxycamptothecin nanosuspensions.
Han M; Liu X; Guo Y; Wang Y; Wang X
Int J Pharm; 2013 Oct; 455(1-2):85-92. PubMed ID: 23928147
[TBL] [Abstract][Full Text] [Related]
28. [Preparation of cationic vancomycin hydrochloride multivesicular liposomes and its quality].
Yang D; Xu Y; Li F; Liu H; He X
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 Apr; 27(4):443-8. PubMed ID: 23757873
[TBL] [Abstract][Full Text] [Related]
29. Liraglutide-loaded multivesicular liposome as a sustained-delivery reduces blood glucose in SD rats with diabetes.
Zhang L; Ding L; Tang C; Li Y; Yang L
Drug Deliv; 2016 Nov; 23(9):3358-3363. PubMed ID: 27099000
[TBL] [Abstract][Full Text] [Related]
30. Encapsulation of 9-nitrocamptothecin, a novel anticancer drug, in biodegradable nanoparticles: factorial design, characterization and release kinetics.
Derakhshandeh K; Erfan M; Dadashzadeh S
Eur J Pharm Biopharm; 2007 Apr; 66(1):34-41. PubMed ID: 17070678
[TBL] [Abstract][Full Text] [Related]
31. [Comparison of bioavailability of two kinds of solid dispersion from 10-hydroxycamptothecin in SD rats in vivo].
Wu XC; Hao HJ; Liu YX; Song XY; Zhang YZ; Zhang HQ
Zhongguo Zhong Yao Za Zhi; 2016 Mar; 41(6):1130-1134. PubMed ID: 28875682
[TBL] [Abstract][Full Text] [Related]
32. Nanodiamonds as intracellular transporters of chemotherapeutic drug.
Li J; Zhu Y; Li W; Zhang X; Peng Y; Huang Q
Biomaterials; 2010 Nov; 31(32):8410-8. PubMed ID: 20692696
[TBL] [Abstract][Full Text] [Related]
33. Stealth PEG-PHDCA niosomes: effects of chain length of PEG and particle size on niosomes surface properties, in vitro drug release, phagocytic uptake, in vivo pharmacokinetics and antitumor activity.
Shi B; Fang C; Pei Y
J Pharm Sci; 2006 Sep; 95(9):1873-87. PubMed ID: 16795003
[TBL] [Abstract][Full Text] [Related]
34. Multivesicular liposome formulations for the sustained delivery of interferon alpha-2b.
Qiu J; Wei XH; Geng F; Liu R; Zhang JW; Xu YH
Acta Pharmacol Sin; 2005 Nov; 26(11):1395-401. PubMed ID: 16225764
[TBL] [Abstract][Full Text] [Related]
35. [Multivesicular liposome sustained delivery of a novel synthetic electropositive Positive GnRH antagonist LXT-101: preparation and in vitro evaluation].
Wang T; Quan DQ
Yao Xue Xue Bao; 2009 Nov; 44(11):1291-6. PubMed ID: 21355329
[TBL] [Abstract][Full Text] [Related]
36. [Preparation and in vitro drug release study of long-circulating hydroxycamptothecin nanoparticles].
Xi N; Hou LB
Zhong Yao Cai; 2010 Apr; 33(4):610-3. PubMed ID: 20845792
[TBL] [Abstract][Full Text] [Related]
37. Pharmacology of drugs formulated with DepoFoam: a sustained release drug delivery system for parenteral administration using multivesicular liposome technology.
Angst MS; Drover DR
Clin Pharmacokinet; 2006; 45(12):1153-76. PubMed ID: 17112293
[TBL] [Abstract][Full Text] [Related]
38. In-vivo pharmacokinetics, tissue distribution and anti-tumour effect of hydroxycamptothecin delivered in oil-in-water submicron emulsions.
Zhao YX; Liu DX; Liang WQ; Ye ZW
J Pharm Pharmacol; 2012 Jun; 64(6):783-91. PubMed ID: 22571256
[TBL] [Abstract][Full Text] [Related]
39. Hydroxycamptothecin-loaded nanoparticles enhance target drug delivery and anticancer effect.
Wang A; Li S
BMC Biotechnol; 2008 May; 8():46. PubMed ID: 18454874
[TBL] [Abstract][Full Text] [Related]
40. Clinical applications of a novel sustained-release injectable drug delivery system: DepoFoam technology.
Howell SB
Cancer J; 2001; 7(3):219-27. PubMed ID: 11419030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
